Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol

Michael Peter Diamond, Wayne S. Maxson, William K. Vaughn, Kevin G. Osteen, Anne Colston Wentz

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

End-organ antiestrogenic effects of clomiphene citrate (CC) have been demonstrated in the female reproductive tract at the levels of the ovary, cervix, and endometrium. However, it has not been established whether this effect is manifested during concomitant human menopausal gonadotropin (hMG) administration, as occurs in hMG/ CC stimulations of multiple follicular development. To assess this question a review was made of serum estradiol (E2) and cervical mucus in 47 hMG and 56 hMG/CC stimulations on days-2,-1,0, and+1 relative to the day of hCG administration. E2 levels (pg/ml) were significantly lower in the hMG as compared to the hMG/CC group. However, comparing the hMG and hMG/CC groups, cervical mucus scores were significantly higher in the former. Furthermore, an analysis of covariance demonstrated that the cervical mucus scores on each day were significantly lower in the hMG/CC group (P<0.001). Thus, in hMG/CC stimulations for in vitro fertilization (IVF), despite the concomitant administration of pharmacologic doses of hMG, CC exerts an antiestrogenic effect on at least one end organ, cervical mucus production. Potentially, this antiestrogenic effect in IVF stimulations would be exerted at other female reproductive tract sites including the endometrium; however, its clinical significance, if any, is unclear.

Original languageEnglish (US)
Pages (from-to)106-109
Number of pages4
JournalJournal of in Vitro Fertilization and Embryo Transfer
Volume3
Issue number2
DOIs
StatePublished - Apr 1 1986
Externally publishedYes

Fingerprint

Menotropins
Clomiphene
Cervix Mucus
Fertilization in Vitro
Endometrium
Cervix Uteri
Ovary
Estradiol

Keywords

  • antiestrogenic effect
  • cervical mucus
  • clomiphene citrate
  • in vitro fertilization

ASJC Scopus subject areas

  • Embryology
  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Developmental Biology

Cite this

Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol. / Diamond, Michael Peter; Maxson, Wayne S.; Vaughn, William K.; Osteen, Kevin G.; Colston Wentz, Anne.

In: Journal of in Vitro Fertilization and Embryo Transfer, Vol. 3, No. 2, 01.04.1986, p. 106-109.

Research output: Contribution to journalArticle

Diamond, Michael Peter ; Maxson, Wayne S. ; Vaughn, William K. ; Osteen, Kevin G. ; Colston Wentz, Anne. / Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol. In: Journal of in Vitro Fertilization and Embryo Transfer. 1986 ; Vol. 3, No. 2. pp. 106-109.
@article{2f65103b6ed748e1a33ebedc256548fb,
title = "Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol",
abstract = "End-organ antiestrogenic effects of clomiphene citrate (CC) have been demonstrated in the female reproductive tract at the levels of the ovary, cervix, and endometrium. However, it has not been established whether this effect is manifested during concomitant human menopausal gonadotropin (hMG) administration, as occurs in hMG/ CC stimulations of multiple follicular development. To assess this question a review was made of serum estradiol (E2) and cervical mucus in 47 hMG and 56 hMG/CC stimulations on days-2,-1,0, and+1 relative to the day of hCG administration. E2 levels (pg/ml) were significantly lower in the hMG as compared to the hMG/CC group. However, comparing the hMG and hMG/CC groups, cervical mucus scores were significantly higher in the former. Furthermore, an analysis of covariance demonstrated that the cervical mucus scores on each day were significantly lower in the hMG/CC group (P<0.001). Thus, in hMG/CC stimulations for in vitro fertilization (IVF), despite the concomitant administration of pharmacologic doses of hMG, CC exerts an antiestrogenic effect on at least one end organ, cervical mucus production. Potentially, this antiestrogenic effect in IVF stimulations would be exerted at other female reproductive tract sites including the endometrium; however, its clinical significance, if any, is unclear.",
keywords = "antiestrogenic effect, cervical mucus, clomiphene citrate, in vitro fertilization",
author = "Diamond, {Michael Peter} and Maxson, {Wayne S.} and Vaughn, {William K.} and Osteen, {Kevin G.} and {Colston Wentz}, Anne",
year = "1986",
month = "4",
day = "1",
doi = "10.1007/BF01139355",
language = "English (US)",
volume = "3",
pages = "106--109",
journal = "Journal of Assisted Reproduction and Genetics",
issn = "1058-0468",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Antiestrogenic effect of clomiphene citrate in a multiple follicular stimulation protocol

AU - Diamond, Michael Peter

AU - Maxson, Wayne S.

AU - Vaughn, William K.

AU - Osteen, Kevin G.

AU - Colston Wentz, Anne

PY - 1986/4/1

Y1 - 1986/4/1

N2 - End-organ antiestrogenic effects of clomiphene citrate (CC) have been demonstrated in the female reproductive tract at the levels of the ovary, cervix, and endometrium. However, it has not been established whether this effect is manifested during concomitant human menopausal gonadotropin (hMG) administration, as occurs in hMG/ CC stimulations of multiple follicular development. To assess this question a review was made of serum estradiol (E2) and cervical mucus in 47 hMG and 56 hMG/CC stimulations on days-2,-1,0, and+1 relative to the day of hCG administration. E2 levels (pg/ml) were significantly lower in the hMG as compared to the hMG/CC group. However, comparing the hMG and hMG/CC groups, cervical mucus scores were significantly higher in the former. Furthermore, an analysis of covariance demonstrated that the cervical mucus scores on each day were significantly lower in the hMG/CC group (P<0.001). Thus, in hMG/CC stimulations for in vitro fertilization (IVF), despite the concomitant administration of pharmacologic doses of hMG, CC exerts an antiestrogenic effect on at least one end organ, cervical mucus production. Potentially, this antiestrogenic effect in IVF stimulations would be exerted at other female reproductive tract sites including the endometrium; however, its clinical significance, if any, is unclear.

AB - End-organ antiestrogenic effects of clomiphene citrate (CC) have been demonstrated in the female reproductive tract at the levels of the ovary, cervix, and endometrium. However, it has not been established whether this effect is manifested during concomitant human menopausal gonadotropin (hMG) administration, as occurs in hMG/ CC stimulations of multiple follicular development. To assess this question a review was made of serum estradiol (E2) and cervical mucus in 47 hMG and 56 hMG/CC stimulations on days-2,-1,0, and+1 relative to the day of hCG administration. E2 levels (pg/ml) were significantly lower in the hMG as compared to the hMG/CC group. However, comparing the hMG and hMG/CC groups, cervical mucus scores were significantly higher in the former. Furthermore, an analysis of covariance demonstrated that the cervical mucus scores on each day were significantly lower in the hMG/CC group (P<0.001). Thus, in hMG/CC stimulations for in vitro fertilization (IVF), despite the concomitant administration of pharmacologic doses of hMG, CC exerts an antiestrogenic effect on at least one end organ, cervical mucus production. Potentially, this antiestrogenic effect in IVF stimulations would be exerted at other female reproductive tract sites including the endometrium; however, its clinical significance, if any, is unclear.

KW - antiestrogenic effect

KW - cervical mucus

KW - clomiphene citrate

KW - in vitro fertilization

UR - http://www.scopus.com/inward/record.url?scp=0022572809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022572809&partnerID=8YFLogxK

U2 - 10.1007/BF01139355

DO - 10.1007/BF01139355

M3 - Article

C2 - 3084690

AN - SCOPUS:0022572809

VL - 3

SP - 106

EP - 109

JO - Journal of Assisted Reproduction and Genetics

JF - Journal of Assisted Reproduction and Genetics

SN - 1058-0468

IS - 2

ER -